{"id":9638,"date":"2022-06-08T11:05:48","date_gmt":"2022-06-08T10:05:48","guid":{"rendered":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/"},"modified":"2022-07-12T09:49:55","modified_gmt":"2022-07-12T08:49:55","slug":"uk-launch-new-blood-test-for-prostate-cancer","status":"publish","type":"post","link":"https:\/\/www.x4lifesciences.com\/de\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/","title":{"rendered":"UK launch new blood test for prostate cancer"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><p>[vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;dark&#8220;][vc_column][vc_column_text]<\/p>\n<h6><strong>MDNA Life Sciences has announced that its Mitomic Prostate Test is now available in the UK for clinical use following a launch by Aspire Pharma.<\/strong><\/h6>\n<p>The MPT is considered as the world\u2019s most\u00a0<a href=\"http:\/\/www.pharmatimes.com\/news\/worlds_most_accurate_blood_test_launched_in_uk_1294791\">accurate blood test<\/a>\u00a0in determining whether a man does or does not have prostate cancer that will require a form of treatment. The test works by taking advantage of the distinctive characteristics of mutations in mitochondrial DNA as biomarkers which can signify existing clinically significant prostate cancer.[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;light&#8220;][vc_column][vc_column_text]<\/p>\n<p style=\"padding-top: 5px\"> <strong><\/p>\n<p><strong><a href=\"https:\/\/www.med-technews.com\/news\/new-blood-test-for-prostate-cancer-launched-in-the-uk\/\">Statistics<\/a><\/strong><\/p>\n<ul>\n<li>A clinical study has found that the MPT biomarker has a higher than 99% negative predictive value. This means that men with a negative MPT result are highly unlikely to have clinically significant prostate cancer. Once this result is determined there is little requirement for further testing<\/li>\n<li>The MPT has a 92% sensitivity. The outcome of which means men with a positive result are referred for immediate medical assistance<\/li>\n<li>Prostate cancer testing is heavily reliant on measuring PSA levels at present, and this can give false-positive results \u2013 the MPT however, can help reduce the number of prostate biopsies by up to 30%<\/li>\n<\/ul>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;dark&#8220;][vc_column][vc_column_text]<\/p>\n<p style=\"padding-top: 30px\"> The test will be available privately and carried out by private healthcare clinics. All testing and results reporting will take place in HMR Labs in London. Aspire Pharma, a partner of MDNA, are actively working with the NHS on longer term plans to make these blood test more accessible and widely available. In addition, it will cut a lot of costs for the health system whilst reducing stress for many men.<\/p>\n<p>Harry Smart, MDN Life Sciences chairman confirmed, \u201cIn parallel with the launch of MPT in the private health sector, plans are under way to make it available in the NHS.\u201d[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>[vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;dark&#8220;][vc_column][vc_column_text] MDNA Life Sciences has announced that its Mitomic Prostate Test is now available in the UK for clinical use following a launch&#8230;<\/p>\n","protected":false},"author":1,"featured_media":9833,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[239,320],"tags":[],"class_list":["post-9638","post","type-post","status-publish","format-standard","hentry","category-insights","category-thought-leadership"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.4 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>UK launch new blood test for prostate cancer - X4 Life Sciences<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UK launch new blood test for prostate cancer\" \/>\n<meta property=\"og:description\" content=\"[vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;dark&#8220;][vc_column][vc_column_text] MDNA Life Sciences has announced that its Mitomic Prostate Test is now available in the UK for clinical use following a launch...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"X4 Life Sciences\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-08T10:05:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-07-12T08:49:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"655\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"x4group_cms\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"x4group_cms\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/\"},\"author\":{\"name\":\"x4group_cms\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/7b98a0a3e9518ee1471a804ae06c7889\"},\"headline\":\"UK launch new blood test for prostate cancer\",\"datePublished\":\"2022-06-08T10:05:48+00:00\",\"dateModified\":\"2022-07-12T08:49:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/\"},\"wordCount\":353,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/06\\\/LS-Insights-Blog-Posts-10.jpg\",\"articleSection\":[\"Insights\",\"Thought Leadership\"],\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/\",\"name\":\"UK launch new blood test for prostate cancer - X4 Life Sciences\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/06\\\/LS-Insights-Blog-Posts-10.jpg\",\"datePublished\":\"2022-06-08T10:05:48+00:00\",\"dateModified\":\"2022-07-12T08:49:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/7b98a0a3e9518ee1471a804ae06c7889\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#breadcrumb\"},\"inLanguage\":\"de-DE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de-DE\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/06\\\/LS-Insights-Blog-Posts-10.jpg\",\"contentUrl\":\"https:\\\/\\\/www.x4lifesciences.com\\\/wp-content\\\/uploads\\\/sites\\\/21\\\/2022\\\/06\\\/LS-Insights-Blog-Posts-10.jpg\",\"width\":1200,\"height\":655},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/2022\\\/06\\\/08\\\/uk-launch-new-blood-test-for-prostate-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.x4lifesciences.com\\\/de\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UK launch new blood test for prostate cancer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#website\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/\",\"name\":\"X4 Life Sciences\",\"description\":\"Life Sciences Recruitment Specialists\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.x4lifesciences.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de-DE\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.x4lifesciences.com\\\/#\\\/schema\\\/person\\\/7b98a0a3e9518ee1471a804ae06c7889\",\"name\":\"x4group_cms\",\"url\":\"https:\\\/\\\/www.x4lifesciences.com\\\/de\\\/author\\\/x4group_cms\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UK launch new blood test for prostate cancer - X4 Life Sciences","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/","og_locale":"de_DE","og_type":"article","og_title":"UK launch new blood test for prostate cancer","og_description":"[vc_row full_width=&#8220;stretch_row&#8220; el_class=&#8220;dark&#8220;][vc_column][vc_column_text] MDNA Life Sciences has announced that its Mitomic Prostate Test is now available in the UK for clinical use following a launch...","og_url":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/","og_site_name":"X4 Life Sciences","article_published_time":"2022-06-08T10:05:48+00:00","article_modified_time":"2022-07-12T08:49:55+00:00","og_image":[{"width":1200,"height":655,"url":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg","type":"image\/jpeg"}],"author":"x4group_cms","twitter_card":"summary_large_image","twitter_misc":{"Written by":"x4group_cms","Est. reading time":"2 Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#article","isPartOf":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/"},"author":{"name":"x4group_cms","@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/7b98a0a3e9518ee1471a804ae06c7889"},"headline":"UK launch new blood test for prostate cancer","datePublished":"2022-06-08T10:05:48+00:00","dateModified":"2022-07-12T08:49:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/"},"wordCount":353,"commentCount":0,"image":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg","articleSection":["Insights","Thought Leadership"],"inLanguage":"de-DE","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/","url":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/","name":"UK launch new blood test for prostate cancer - X4 Life Sciences","isPartOf":{"@id":"https:\/\/www.x4lifesciences.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#primaryimage"},"thumbnailUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg","datePublished":"2022-06-08T10:05:48+00:00","dateModified":"2022-07-12T08:49:55+00:00","author":{"@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/7b98a0a3e9518ee1471a804ae06c7889"},"breadcrumb":{"@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#breadcrumb"},"inLanguage":"de-DE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"de-DE","@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#primaryimage","url":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg","contentUrl":"https:\/\/www.x4lifesciences.com\/wp-content\/uploads\/sites\/21\/2022\/06\/LS-Insights-Blog-Posts-10.jpg","width":1200,"height":655},{"@type":"BreadcrumbList","@id":"https:\/\/www.x4lifesciences.com\/2022\/06\/08\/uk-launch-new-blood-test-for-prostate-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.x4lifesciences.com\/de\/"},{"@type":"ListItem","position":2,"name":"UK launch new blood test for prostate cancer"}]},{"@type":"WebSite","@id":"https:\/\/www.x4lifesciences.com\/#website","url":"https:\/\/www.x4lifesciences.com\/","name":"X4 Life Sciences","description":"Life Sciences Recruitment Specialists","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.x4lifesciences.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de-DE"},{"@type":"Person","@id":"https:\/\/www.x4lifesciences.com\/#\/schema\/person\/7b98a0a3e9518ee1471a804ae06c7889","name":"x4group_cms","url":"https:\/\/www.x4lifesciences.com\/de\/author\/x4group_cms\/"}]}},"_links":{"self":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/9638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/comments?post=9638"}],"version-history":[{"count":2,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/9638\/revisions"}],"predecessor-version":[{"id":9837,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/posts\/9638\/revisions\/9837"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/media\/9833"}],"wp:attachment":[{"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/media?parent=9638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/categories?post=9638"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.x4lifesciences.com\/de\/wp-json\/wp\/v2\/tags?post=9638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}